Pages that link to "Q35671533"

The following pages link to Fosfomycin kinetics after intravenous and oral administration to human volunteers (Q35671533):

Displaying 23 items.

• Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections (Q34057525) (← links)
• 'Old' antibiotics for emerging multidrug-resistant bacteria (Q34565772) (← links)
• Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults (Q35310871) (← links)
• Fosfomycin (Q36675246) (← links)
• Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae (Q37023175) (← links)
• Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model. (Q37287661) (← links)
• Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods. (Q38325217) (← links)
• When sepsis persists: a review of MRSA bacteraemia salvage therapy (Q38632488) (← links)
• Fosfomycin suppresses RS-virus-induced Streptococcus pneumoniae and Haemophilus influenzae adhesion to respiratory epithelial cells via the platelet-activating factor receptor (Q39680379) (← links)
• Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers (Q40166194) (← links)
• Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis (Q40901796) (← links)
• Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans (Q42930222) (← links)
• Control of Salmonella enteritidis phage type 4 experimental infection by fosfomycin in newly hatched chicks (Q43741021) (← links)
• Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity (Q43805708) (← links)
• Efficacy of phosphomycin in the control of Escherichia coli infection of broiler chickens (Q43930310) (← links)
• Intracellular bactericidal activity of fosfomycin against staphylococci: A comparison with other antibiotics (Q44494061) (← links)
• Pharmacokinetics of disodium fosfomycin in broilers and dose strategies to comply with its pharmacodynamics versus Escherichia coli (Q45576659) (← links)
• Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses (Q46475412) (← links)
• Fosfomycin: Pharmacological, Clinical and Future Perspectives. (Q47136072) (← links)
• Clinical effects of 2 days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women (Q51548358) (← links)
• Pharmacokinetics and Pharmacodynamics of Fosfomycin and its Activity against ESBL-, Plasmid-mediated AmpC- and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model (Q51734361) (← links)
• New perspectives for reassessing fosfomycin: applicability in current clinical practice. (Q64945950) (← links)
• Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase (Q92613730) (← links)